| # | Drug | Count |
|---|---|---|
| 0 | PREDNISOLONE | 20 |
| 1 | PREDNISOLONE ORAL | 20 |
| 2 | PREDNISOLONE ORAL SOLUTION | 20 |
| 3 | BELIMUMAB | 19 |
| 4 | HYDROXYCHLOROQUINE | 12 |
| 5 | TACROLIMUS | 12 |
| 6 | MYCOPHENOLATE MOFETIL | 11 |
| 7 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 11 |
| 8 | PREDNISONE | 9 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANCRELIPASE LIPASE, PANCRELIPASE AMYLASE, AND PANCRELIPASE PROTEASE | 1 | 0.0015 |
| 1 | SODIUM FLUORIDE AND POTASSIUM NITRATE | 1 | 0.0010 |
| 2 | DOXYCYCLINE MONOHYDRATE | 1 | 0.0006 |
| 3 | BELIMUMAB | 19 | 0.0006 |
| 4 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| 5 | ANIFROLUMAB-FNIA | 1 | 0.0005 |
| 6 | ESTRADIOL/NORETHINDRONE ACETATE | 1 | 0.0005 |
| 7 | MANNITOL | 2 | 0.0004 |
| 8 | ARTIFICIAL TEARS | 1 | 0.0004 |
| 9 | POLYVINYL ALCOHOL, POVIDONE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 19 | 0.0006 |
| 1 | Osmotic Diuretic [EPC] | 2 | 0.0004 |
| 2 | Plasma Volume Expander [EPC] | 1 | 0.0003 |
| 3 | Bismuth [EPC] | 1 | 0.0002 |
| 4 | Barbiturate [EPC] | 1 | 0.0001 |
| 5 | Prostaglandin E1 Analog [EPC] | 1 | 0.0001 |
| 6 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 3 | 0.0000 |
| 8 | Prostacyclin Receptor Agonist [EPC] | 1 | 0.0000 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 4 | 0.0000 |